Previous Article | Next Article ![]()
Infection and Immunity, November 1999, p. 5736-5746, Vol. 67, No. 11
Departments of
Periodontics1 and
Microbiology,2 University of Texas
Health Science Center at San Antonio, San Antonio, Texas
Received 30 March 1999/Returned for modification 28 May
1999/Accepted 30 July 1999
This study investigated the characteristics of humoral immune
responses to Treponema denticola following primary
infection, reinfection, and active immunization, as well as immune
protection in mice. Primary infection with T. denticola
induced a significant (400-fold) serum immunoglobulin G (IgG) response
compared to that in control uninfected mice. The IgG response to
reinfection was 20,000-fold higher than that for control mice and
10-fold higher than that for primary infection. Mice actively immunized
with formalin-killed treponemes developed serum antibody levels seven- to eightfold greater than those in animals after primary infection. Nevertheless, mice with this acquired antibody following primary infection or active immunization demonstrated no significant
alterations of lesion induction or decreased size of the abscesses
following a challenge infection. Mice with primary infection developed
increased levels of IgG3, IgG2b, and IgG2a antibodies, with IgG1 being
lower than the other subclasses. Reinfected mice developed enhanced IgG2b, IgG2a, and IgG3 and less IgG1. In contrast, immunized mice developed higher IgG1 and lower IgG3 antibody responses to infection. These IgG subclass distributions indicate a stimulation of both Th1 and
Th2 activities in development of the humoral immune response to
infection and immunization. Our findings also demonstrated a broad
antigen reactivity of the serum antibody, which was significantly increased with reinfection and active immunization. Furthermore, serum
antibody was effective in vitro in immobilizing and clumping the
bacteria but did not inhibit growth or passively prevent the treponemal
infection. These observations suggest that humoral immune responses, as
manifested by antibody levels, isotype, and antigenic specificity, were
not capable of resolving a T. denticola infection.
Oral treponemes have been implicated
as etiological agents of severe periodontal disease in adults. The oral
spirochetes Treponema denticola, T. socranskii,
T. pectinovorum, T. vincentii, T. maltophilum, T. medium, and T. amylovorum
and the pathogen-related oral spirochetes have been found to be
associated with human periodontal disease (3, 29, 38, 45, 46, 50,
54, 55), necrotizing ulcerative periodontitis (33),
acute necrotizing ulcerative gingivitis (21), and human
immunodeficiency virus-associated periodontal diseases (41).
T. denticola has been the most extensively studied of the
oral treponemes (18) and is the predominant spirochete identified within the gingival crevice and subgingival ecology of the
developing periodontal pocket of various forms of periodontitis (44).
A limited group of human studies have investigated the characteristics
of humoral immune responses to the oral treponemes (13). In
general, antibodies of multiple isotypes have been detected in human
sera; however, the relationship between levels of these antibodies and
periodontal disease was quite variable (4, 13, 20, 27, 30).
A detailed study of serum antibody responses to oral spirochetes (e.g.,
T. denticola and T. socranskii subspecies) in
severe periodontitis, juvenile periodontitis, and healthy patients was
reported (48, 49). The data showed a higher frequency of
juvenile periodontitis patients seropositive to T. denticola, T. socranskii subsp. buccale, and
T. socranskii subsp. paredis; the patients with
severe periodontitis had a uniformly low level or absence of antibody
to the treponemes. While these treponemes were present in all patient
groups, including those with severe periodontitis (i.e., some of the
isolates were actually cultivated from these patients), the level of
antibody was not consistent with the burden of these species in the
plaque. Less work has been done on evaluating humoral immune responses
to the oral treponemes in animal models. We have noted that even with ligature-induced periodontitis in Macaca fascicularis, in
which substantial increases in T. denticola in the plaque
from diseased sites have been reported, the antibody response was quite
low (unpublished observations). Also, our preliminary studies
demonstrated a virtual absence of serum antibody to T. denticola in normal mice (unpublished observations).
The murine abscess model has been successfully utilized in examining
the pathogenesis of oral bacterial infections, including Porphyromonas gingivalis (16, 22),
Campylobacter rectus (24), and
Actinobacillus actinomycetemcomitans (16). In
these studies, increased levels of the pathogens within the murine host
resulted in concomitant increases in humoral immune responses to the
microorganisms. The purpose of this investigation, therefore, was to
evaluate the immunologic characteristics of T. denticola
infection in a murine model. Our preliminary studies suggested a lack
of immune protection against T. denticola, in contrast to
protection in mice with other oral pathogens, such as P. gingivalis and C. rectus (22, 24).
Accordingly, four hypotheses were tested in this investigation. The
first was that a minimal humoral immune response is induced by
infection with the treponemes and that infection would be thus
ineffective in providing protection against a subsequent reinfection.
However, if antibody was elicited, it would have minimal functional
capabilities for interfering with T. denticola infection.
Alternatively, the ineffectiveness of the antibody would be associated
with a skewed immunoglobulin G (IgG) subclass distribution, resulting
in a lack of immune protection. Finally, antibody produced to T. denticola would be directed to a limited antigen repertoire and
thus reflect the lack of humoral immunity to T. denticola infection.
Bacterial strains and growth conditions.
T. denticola
ATCC 35404 (16, 23, 25, 51), a type strain of this species,
was grown in GM-1 broth (7) or modified NOS medium
(51) for 72 h in a Coy anaerobic chamber in an
atmosphere of 85% N2, 5% CO2, and 10%
H2 at 37°C. All manipulations were carried out under
anaerobic conditions to ensure maximum cell viability. Culture purity
of the treponemes was determined by dark-field and phase-contrast
microscopy, with culture viability being estimated by the degree of
motility and presence or absence of spherical bodies of the treponemes
(23, 25). Log-phase cultures were harvested by
centrifugation (9,000 × g for 10 min), and pellets
were resuspended in fresh GM-1 broth under anaerobic conditions. An
aliquot of the culture was removed from the chamber, and 10-fold
dilutions were made in GM-1 broth for estimating total counts with a
Petroff-Hausser bacterial counting chamber. The cells were enumerated,
excluding spherical bodies.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Lack of Humoral Immune Protection against
Treponema denticola Virulence in a Murine Model
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Mice. ICR (Harlan Sprague-Dawley Inc., Indianapolis, Ind.) female mice aged 8 to 12 weeks old were used in these studies. The animals were housed in isolator cages in an accredited (American Association for Accreditation of Laboratory Animal Care) animal facility at the University of Texas Health Science Center at San Antonio. Animals were provided autoclaved TEKLAD chow (Harlan Sprague-Dawley Inc., Madison, Wis.) and water ad libitum.
Murine virulence model. The murine abscess model (15) as modified by Kesavalu et al.(22, 24, 25) was used to examine the virulence capacities of T. denticola and P. gingivalis. For determination of virulence and abscess-forming capability, bacterial dilutions (5 × 1010 for T. denticola and 2 × 1010 for P. gingivalis) were made in GM-1 medium (T. denticola) or reduced transport fluid (P. gingivalis) under anaerobic conditions as described previously (16, 22, 23). Mice were injected subcutaneously (s.c.) within 15 to 30 min of the bacterial preparation. After primary infection, the animals were monitored daily for symptoms of infection, and virulence was scored as the size of a localized abscess and/or necrotic spreading skin lesion and death. Sizes (length and width) of s.c. abscesses and necrotic spreading lesions were measured with a caliper gauge, and the area was determined and expressed in square millimeters. Our previous study (23) demonstrated that mice injected s.c. with GM-1 medium demonstrated neither toxicity nor any lesion at the site of injection. After the lesions healed (14 to 21 days), selected groups of mice were reinfected on the contralateral side of the back.
Active immunization. Both T. denticola and P. gingivalis were grown as described above, and the cells were harvested by centrifugation and suspended overnight in 0.5% (vol/vol) buffered formal saline (formalin-killed [F-K] cells). Formalin-treated cells were washed three times with sterile phosphate-buffered saline (PBS), and the total counts, purity, and sterility were determined (22, 24, 25). F-K cells were stored at 4°C for use in active immunization and also for coating microtiter plates for enzyme-linked immunosorbent assay (ELISA). Mice were immunized by s.c. injection into the nape of the neck with 0.1 ml of 109 F-K T. denticola or P. gingivalis cells emulsified in incomplete Freund's adjuvant (IFA). The control placebo-treated mice received IFA emulsified with sterile PBS, pH 7.2. A booster immunization of an identical preparation was administered 2 weeks later. Following booster immunization, two groups of mice were examined: (i) mice subjected to primary infection plus active immunization and (ii) mice subjected to active immunization alone. Both groups were challenged s.c. with viable T. denticola (5 × 1010 cells) approximately 2 weeks after the booster immunization. Following s.c. lesion healing and/or immunization, blood was collected and serum was prepared for antibody analysis.
Antibody analyses. Blood for serum samples was collected after primary infection, reinfection, and active immunization by retro-orbital access either under general inhalation anesthesia or after CO2-induced euthanasia. IgG, IgM, and IgG subclass (IgG1, IgG2a, IgG2b, and IgG3) antibodies were determined by ELISA (15). Briefly, formalin-killed T. denticola or P. gingivalis cells were applied to microtiter plates and left overnight at 4°C. After washing, the sera were serially diluted in PBS containing 0.05% Tween 20 (Sigma, St. Louis, Mo.) in microtiter plates and incubated for 2 h at room temperature on a rotator. Biotin-conjugated goat anti-mouse IgG (Fc specific; Sigma) and IgM (µ chain specific; Sigma) were added (1:5,000) to the washed plates and incubated for an additional 2 h at room temperature on a rotator. After washing, streptavidin-alkaline phosphatase (1:1,000; Zymed, South San Francisco, Calif.) was added and incubated overnight at room temperature on a rotator. The substrate (p-nitrophenylphosphate; 1 mg/ml) was added to the washed plates, and the reaction was terminated by using 1 N NaOH. For IgG subclass ELISA analysis, goat anti-mouse IgG1, IgG2a, IgG2b, and IgG3 (heavy chain specific; Sigma), and alkaline phosphatase-conjugated rabbit anti-goat IgG (whole molecule; Sigma) were used. The optical density (OD) was measured spectrophotometrically at 405 nm (Dynatech MRX Plate Reader). Duplicate serial dilutions were used to construct curves relating the OD to the log2 of the dilution. From these individual curves, a linear dilution range was determined, and the antibody level was expressed in units described by the OD multiplied by the lowest dilution of the serum with an OD in the linear range of the ELISA curves. Normal pooled ICR mouse serum and either primary or reinfected serum were used as negative and positive controls, respectively.
Treponemal antigen.
T. denticola was grown to late
logarithmic phase, and soluble antigen was prepared as described by
Wicher et al. (53). The cells were pelleted by
centrifugation (9,000 × g for 10 min), washed three
times with sterile PBS (137 mM NaCl, 2.5 mM
KH2PO4, 7 mM K2HPO4
[pH 7.2]), enumerated, and resuspended in PBS at 2 × 1010 cells/ml. The proteinase inhibitors
phenylmethylsulfonyl fluoride and
N-p-Tosyl-L-lysine chloromethyl ketone (2 mM
each) were added. The cells were broken by sonication at ice bath
temperature in six to eight 1-min cycles for complete disruption with a
Cell Disruptor 200 (Branson Sonifier) and dissolved with 2% sodium N-laurylsarcosine for 30 min at 37°C. The protein
concentration of the treponemal antigen was determined by the
bicinchoninic acid procedure (Pierce Chemical Co., Rockford, Ill.) and
the preparation was aliquoted and stored at
70°C until use.
Electrophoresis. Discontinuous sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed on a 10% gel as described by Laemmli (26). SDS-polyacrylamide gels were stained with Coomassie brilliant blue R250 (Bio-Rad Laboratories, Hercules, Calif.) or by silver staining (Bio-Rad). Bio-Rad low-range molecular weight standards were used to estimate the molecular masses of T. denticola proteins.
Western immunoblotting. T. denticola ATCC 35404 soluble antigen polypeptides were separated by SDS-10% PAGE. The proteins were electrophoretically transferred onto nitrocellulose paper (0.25-µm pore size; Schleicher & Schuell, Inc., Keene, N.H.) by using 25 mM Tris-192 mM glycine-20% methanol buffer (pH 8.3) at 8 V/cm for 3 h at 4°C (14). The nitrocellulose sheets were dried and then incubated for 4 h at 25°C in a blocking solution (1% bovine serum albumin in 10 mM Tris-buffered saline). Transferred proteins were probed with 1:2,000 dilutions of three individual mouse sera, from (i) primary infection, (ii) primary infection plus reinfection, and (iii) active immunization plus primary infection, by overnight incubation at 25°C. The bound antibody was identified with goat anti-mouse IgG1, IgG2a, IgG2b, and IgG3 (1:1,000) by incubation for 2 h at room temperature. The blots were washed, rabbit anti-goat IgG (whole molecule) conjugated to alkaline phosphatase (1:2,000) was added, and the mixture was incubated for 2 to 4 h at room temperature. After washing, the nitrocellulose blots were developed with a 5-bromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium substrate system (Sigma) according to the manufacturer's specifications. Molecular weights of the T. denticola polypeptides reacting with infected and immunized mouse sera were interpolated from known Bio-Rad Kaleidoscope prestained low-range molecular weight standards (14).
Immune immobilization of T. denticola. T. denticola cultures were grown for 24 to 48 h. The T. denticola immobilization assay was modified from that described for T. pallidum (35, 37). Briefly, the treponemes with active motility were suspended at 108 cells per ml in NOS medium in sterile Microfuge tubes (79 µl) and mixed with pooled (n = 5) heat-inactivated (56°C, 30 min) primary infection, reinfection, or active-immunization mouse serum (11 µl) with unheated rabbit serum (undiluted) as a source of complement (10 µl). Heat-inactivated pooled normal mouse serum (undiluted) was used as a negative control. All manipulations were carried out under anaerobic conditions to ensure maximum cell viability. Aliquots were removed at 3 and 6 h for determination of motility, immobilization, and type of aggregation of cells (small and large clumps) by using dark-field phase-contrast microscopy. All immobilization assays were performed in duplicate on two different occasions to ensure consistency of the data.
In vitro immune function on growth kinetics. To determine the cytotoxic function of the specific immune antibody on viability and growth of T. denticola, a 48-h-grown culture (160 µl) was mixed with (20 µl) of pooled (n = 5) heat-inactivated primary-infection serum (1:10, 1:100, or 1:1,000), normal mouse serum, and/or undiluted rabbit complement (20 µl) in tubes for 3 h under anaerobic conditions. Pooled, heat-inactivated normal mouse serum (undiluted) was used as a negative control. Ten milliliters of NOS medium was added to each tube after 3 h of exposure, mixed thoroughly, and incubated for an additional 72 h. At 24, 48, and 72 h postincubation, 1 ml of culture was removed from each tube, and growth was determined by measurement of OD at 660 nm. Culture purity was examined by phase-contrast microscopy and Gram staining.
In vivo immune antibody function. T. denticola was grown in NOS medium as described above, pelleted by centrifugation, enumerated, and resuspended in fresh NOS medium at 5 × 1010 cells per ml. Pooled heat-inactivated primary infected or normal mouse serum (10%, vol/vol) and rabbit complement (10%, vol/vol) were mixed with viable T. denticola (80% vol/vol) inside the anaerobic chamber. Groups of mice were challenged (s.c. injection) with 1010 treponemes after 1 or 3 h of exposure to the mouse serum and complement. The groups consisted of (i) T. denticola plus primary-infection mouse serum and complement (1 h of exposure), (ii) T. denticola plus primary-infection mouse serum and complement (3 h of exposure), (iii) T. denticola plus normal mouse serum and complement (3 h of exposure), (iv) T. denticola plus complement (3 h of exposure), and (v) T. denticola alone (untreated control). After challenge, the animals were monitored and the lesions were scored. Following s.c. lesion healing, blood was collected, serum was separated, and IgG antibody levels were analyzed by ELISA.
Chemicals. Unless otherwise stated, all the chemicals and reagents were obtained from Sigma Biosciences, St. Louis, Mo.
Statistical analyses. Statistical differences in lesion size or antibody levels among various groups were determined by using a Wilcoxon-Mann-Whitney U test and Fisher's exact test (Minitab, State College, Pa.).
| |
RESULTS |
|---|
|
|
|---|
Virulence of T. denticola in the murine model. In this study we evaluated the immune characteristics and immune protection following primary infection and reinfection with T. denticola in a murine abscess model. Following both primary infection and reinfection, lesion sizes in all animals were approximately 100 mm2 (Fig. 1). There was gross evidence of hyperemia and diffuse edema at the site of inoculation, and by day 4 abscess formation was noted, as described previously (25). Following recovery from the primary T. denticola infection (14 to 21 days), these animals were reinfected on the contralateral dorsolateral surface of the back with 5 × 1010 T. denticola cells (reinfection) to evaluate the characteristics of acquired immune protection. All animals developed localized abscesses similar to those seen in the primary infection, with respect to onset, duration, and lesion characteristics. There was no mortality induced by s.c. infection with T. denticola. The effects of active immunization on T. denticola virulence in mice were evaluated. Both immunized and control mice challenged with viable T. denticola developed localized abscesses of sizes similar to those seen in primary infection or reinfection (Fig. 1).
|
Humoral immune responses to T. denticola. The serum IgG antibody response following primary infection with T. denticola was approximately 400-fold higher (P < 0.0001) than that in control uninfected animals (Fig. 2). Similarly, the primary IgM antibody response was 40-fold higher (P < 0.001) than that in control uninfected animals. Reinfection with T. denticola significantly enhanced serum IgG and IgM antibody levels by approximately 20,000-fold (P < 0.0001) and 150-fold (P < 0.0001) greater than that in control uninfected animals, respectively. Also, the IgG (10-fold; P < 0.005) and IgM (17-fold; P < 0.001) antibody responses from reinfection were greater than those induced by primary infection. Active immunization of the mice with T. denticola induced serum IgG levels similar to those following the reinfection (Fig. 2).
|
Functional activity of antibody to T. denticola.
Immobilization of T. denticola was performed to determine if
the antibodies elicited after primary infection and immunization were
effective in limiting the motility of the treponemes (Table 1). Sera from mice after primary
infection, with or without complement, immobilized all of the
treponemes, resulting in large clumps by 3 h. Similar results were
observed at higher serum dilutions with sera from reinfected mice by 3 to 6 h. There was enhanced aggregation and immobilization of
treponemes at higher dilutions of active-immunization sera, with and
without complement, by 3 h. Neither immobilization nor aggregation
of T. denticola occurred in the presence of normal mouse
serum, indicating the absence of specific immobilizing antibodies. The
bacterial cells were actively motile in control assays with treponemes
alone or treponemes in the presence of complement. In fact, aggregation
and complete immobilization were noted by 30 to 40 min with mixtures
containing immune serum with or without complement (data not shown).
|
|
|
IgG subclass responses to T. denticola. Thus, we had observed that T. denticola is antigenic in the mice, which resulted in elevated levels of serum antibodies. Furthermore, there was some functional activity of the antibody, although this did not translate into a protective immunity. In order to more fully evaluate the characteristics of the antibody, we determined the IgG subclass distribution of the humoral immune response following infection and immunization. Following a primary infection, the IgG3 subclass levels were significantly (P < 0.02) greater than the IgG1, IgG2a, and IgG2b antibody levels (Fig. 4). Additionally, the IgG1 antibody level was significantly less than those of the other IgG subclasses in response to this primary infection. The IgG subclass profiles in response to reinfection appeared generally similar to those for primary infection (Fig. 4). Reinfection significantly (P < 0.003) enhanced serum IgG1, IgG2a, and IgG2b subclass levels (four- to sixfold) over those in primary infection. IgG3 levels were increased to a lesser extent (twofold). As in the primary infection, the IgG1 subclass level was lower than those of other antibody subclasses. The results suggested a particular pattern of response to infection which consisted primarily of the IgG3, IgG2b, and IgG2a subclasses.
|
|
Antigenic specificity of acquired humoral immune responses to
T. denticola.
To assess antigen and antibody specificity in
this model system, Western immunoblotting with solubilized T. denticola antigens was performed. SDS-PAGE demonstrated numerous
protein bands from 18 to ~160 kDa. Similarly, blots reacted with
infected mouse serum demonstrated up to 36 antigen bands (Table
3). Major antigen bands identified by IgG
subclass antibodies in sera from immunized and infected mice were noted
at 95, 77, 75, 70, 60, 55, 40, 30, 29, and 20 kDa (Table 3). While
there were some differences in the major antigens detected by the
different subclasses (e.g., 116 kDa for IgG1 and IgG3, 90, 68, 50, and
38 kDa for IgG1 and IgG2b; and 19 kDa for IgG2b and IgG3), many of the
antigen bands were recognized by multiple subclasses of IgG antibody
(Table 3). The greatest heterogeneity in antigen band frequency
occurred in the mice with primary infection. The characteristics of
sera from reinfected animals were less variable in antigen band
frequency, and similar numbers of antigen bands were detected by each
of the subclasses (Table 4). However,
there were additional antigens detected by the reinfection sera (e.g.,
90, 68, 45, 35, 33, 30, and 20 kDa). Active-immunization sera reacted
to antigen bands which were similar between animals and among IgG
subclasses (Table 4). As was noted with the levels of IgG3 antibody to
the whole microorganism, somewhat fewer antigen bands were detected by
this subclass, and new antigens were detected by other subclasses
compared to the case for primary infection. However, there was no
demonstrable difference in antigens recognized by serum from
reinfection versus active immunization. Specific for the hypothesis
proposed, many antigen bands were commonly reactive with sera from
primary infected, reinfected, and actively immunized mice, although the
intensities of the antigen reactivity and subclass antibody
characteristics varied among the sera. The findings suggest that
T. denticola presents numerous antigens to the host and
elicits a broadly based polyclonal antibody response.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Humoral immune responses to primary infection and reinfection with T. denticola and to active immunization of mice were quantified, immunoglobulin isotype and subclass profiles were determined, immunogenic T. denticola antigens were estimated, and immune functions were assessed. The ultimate importance of the investigation was to elucidate the capacity of the humoral immune response to confer immunity to infection and the characteristics of the response. The initial findings indicated that irrespective of recovery from a primary infection or active immunization, mice were not protected from a subsequent reinfection with T. denticola. Similar results were also noted with other oral treponemes, including T. socranskii, T. vincentii, and T. pectinovorum (unpublished data). In contrast, P. gingivalis and C. rectus infection or immunization induced immune protection in this model (22, 24).
Based on our initial findings, we hypothesized that the animals demonstrate a limited humoral immune response, which results in lack of protection from challenge infection. This concept was also based on the breadth of studies with human periodontitis populations, which showed that there were large numbers of treponemes in the plaque, while a rather minimal and inconsistent systemic antibody response was observed (4, 13, 20, 27, 48, 49). In contrast, the data presented in this study shows that primary infection with T. denticola in mice elicits a substantial serum IgM and IgG antibody response, with normal mice exhibiting no detectable serum antibody. We subsequently compared the actual level of antibody to that detected in a similar system with P. gingivalis, in which significant protection was observed (10, 11, 22). The results indicated that the level of IgG antibody to the treponemes was nearly 30 times greater than the levels of antibody to P. gingivalis following primary infection. Thus, the absence of protection did not appear to be associated with a lack of ability of the mice to mount a substantial antibody response. Moreover, following reinfection, mice generated an even greater IgG response, which was approximately 10 times more than that in the primary infection, but the lesion size was similar to that in the primary infection. Finally, actively immunized mice, whose serum IgG level was similar to that seen in reinfection, were also not protected from T. denticola infection. Consequently, the mice demonstrated a substantial humoral response, although the magnitude of antibody produced could not explain the lack of protective immunity.
Therefore, we hypothesized that this antibody may lack the ability to alter T. denticola growth and/or motility, which are likely important in infections with this pathogen. We observed that there was a gradation from primary infection to reinfection to active immunization in the ability of the specific antibody to aggregate and immobilize the treponemes in vitro. This was generally independent of complement fixation. This type of finding has been correlated with immune resistance to T. pallidum, although the activity against this pathogen was found to be complement dependent (37). While motility of these oral microorganisms has not been directly linked to their ability to colonize the subgingival sulcus, it is generally thought that this capability provides an important strategy for the treponemes to access nutrients within the plaque biofilm (9, 17), as well as being related to their capacity to invade tissues (39). These observations suggest that the serum immobilizing antibody bound to surface molecules of T. denticola, resulting in clumping and inhibiting motility; this has a minimal impact on the in vivo lesion-forming ability.
We then hypothesized that immune immobilization and aggregation would alter the growth characteristics of T. denticola. However, we observed that following total aggregation of the treponemes, they grew to normal densities similar to those of unaggregated cells. Therefore, the in vivo results demonstrating a lack of immune protection could be explained by (i) the antibody produced having a minimal effect on survival, even while aggregating and immobilizing the bacteria, or (ii) the antibody not reaching the infection site. We examined this alternative by mixing antibody-containing serum with T. denticola, incubating the mixture to allow aggregation and immobilization, and challenging mice with these treated treponemes. Thus, we could be assured that the antibody had the opportunity to interact with the treponemes at high levels and sufficiently early during an infectious challenge. The abscess size was somewhat less than that with T. denticola alone, and there was no difference in lesion size between the treponemes treated with immune and control normal sera. Furthermore, no difference in lesion characteristics was observed, even with extended incubation with the immune sera. Consequently, the antibody interacted with the treponemes, altering the physical characteristics of the population (i.e., they were aggregated and less motile), but had a minimal effect on their virulence. We also evaluated the murine antibody response to treponemes treated with immune antibody prior to the infection. The results showed that the humoral immune response of these infected mice was lower than that of mice challenged with T. denticola incubated with either control normal serum or complement, as well as with untreated T. denticola. Our interpretation of this finding was that the immune antibody coated or bound to surface antigens on the treponemes and minimized the subsequent host recognition of surface antigens following a challenge infection. This type of virulence strategy has been identified with T. pallidum, a phenomenon often attributed to an outer coat of host serum proteins wherein virulent T. pallidum reacts poorly with the specific antibodies present in human and rabbit syphilitic sera (1).
Consequently, we had found that T. denticola elicited high levels of antibody, which has the ability to alter some functions of the pathogen, although this did not translate into immune protection. One mechanism to account for these findings is that T. denticola uses a virulence strategy which skews the production of a subclass profile that could not abrogate its pathogenicity. Examples of these types of deviations or shifts of IgG subclass immune responses have been identified with Chlamydia psittaci (52), Mycobacteirum lepraemurium (31), and Trichuris muris (6) infections. The IgG subclass distribution of the antibody following primary infection, reinfection, and active immunization demonstrated a broad subclass response to infection. The predominant response following primary infection and reinfection was the IgG3 subclass, with IgG1 antibody levels being substantially less. Briles et al. (8) first demonstrated that mouse IgG3 antibodies to the phosphocholine determinant of pneumococcal C-carbohydrate and to type 3 pneumococcal polysaccharide were highly protective against experimental pneumococcal infection. In contrast, the predominant IgG3 subclass antibody response to primary infection with T. denticola did not protect against reinfection. It has been shown that IgG2a antibody is the most effective subclass for the induction of macrophage and killer cell antibody-dependent cellular cytotoxicity of tumor cells and the predominant IgG subclass in antibody-mediated protective responses in most viral infections, functioning by opsonization and complement-mediated lysis of viruses and destruction of virus-infected cells (47). The lack of a protective humoral immune response to T. denticola infection in mice correlated with a decreased IgG2a production, potentially reflecting a lack of opsonization and complement-mediated lysis potential of the antibody population. Various studies of the distribution of antibody responses in mice have identified profiles of subclass antibodies which are indicative of primary stimulation of either Th1 or Th2 functions (34, 47). In particular, Th2 cells elicited by immunization confer protective immunity against Borrelia burgdorferi (36), and all helminth parasites induce a dramatic expansion of the Th2 lymphocyte subset (2). Moreover, differential activation of Th1 and Th2 cell subsets results in induction of characteristic IgG subclass responses in Mycobacterium lepraemurium, coxsackievirus group B type 3, Trichuris muris, and Schistosoma mansoni infections (6, 19, 31, 32). The results indicated an initial IgG3 response after infection, suggesting a skewed IgG antibody subclass response which could account for the lack of humoral immune protection. In our study, active immunization of T. denticola with adjuvant, either prior to or following an infection, altered this dominant IgG subclass antibody response. This was noted as a principal IgG1 subclass response (Th2 response) and appeared to minimize the IgG3 response (immunization followed by primary infection) or turn off the IgG3 response (primary infection followed by immunization) (28, 40). This IgG subclass distribution was observed in sera from mice following P. gingivalis infection and accompanying immunity. Our findings were that primary infection and reinfection with P. gingivalis and active immunization elicited a predominant IgG1 antibody response, with the IgG3 response being nearly 8- to 10-fold less. Active immunization of mice with T. denticola shifted or modulated the antibody response to the IgG1 subclass, which was a distribution of subclasses similar to that for P. gingivalis. Consequently, the skewed IgG subclass humoral immune response to T. denticola could not explain the lack of immune protection.
Finally, we used Western immunoblotting to test the hypothesis that the lack of immunity was associated with a limitation in the breadth of antibody reactivities to the antigen repertoire presented by T. denticola. Results from other bacterial and helminth infections have indicated that selected pathogens utilize immune evasion strategies in which the host is unable to recognize critical antigens used for virulence determinants. This has been associated with antigenic mimicry in parasitic helminths (2) and antigenic variation in trypanosomes, Neisseria gonorrhoeae, and B. burgdorferi (43). More recently, an immunodominant peptide motif in a lipoprotein antigen of T. pallidum with multiple repeats of amino acid sequences in human fibronectin was identified (5). This mimicry was suggested to be active in initially triggering anti-host protein responses associated with disseminated syphilis, with subsequent expansion of the responses by other self-epitopes. In contrast, our results demonstrated a broad reactivity of antibody to numerous T. denticola antigens. Intense reactions to many antigens were observed, which were somewhat characteristic of the individual subclasses of antibody. In addition, selected antigens elicited strong reactions with multiple IgG subclass antibodies. In comparing the frequencies of antigens detected, it appeared that mice with primary infection exhibited a more variable response, which reflected the subclass distribution of the total IgG antibody. More homogeneous responses were noted following reinfection and active immunization. Thus, while we could not determine, in this study design, whether T. denticola had critical virulence determinants to which the mice lacked a humoral immune response, the results demonstrated a gradual but continual increase in the number of antigens recognized from primary infection, to reinfection, to active immunization. These observations are in parallel with those for T. pallidum infection, where mice responded slowly but recognized increasing numbers of antigens during infection (42). Consequently, these findings favored an interpretation that the lack of protective immunity was not due to a limited specificity of the antibody repertoire.
Recent data have suggested that the major protective T. pallidum immunogens are not surface exposed, since treponemes with disrupted outer membranes were markedly more antigenic than intact treponemes, and the limited antigenicity of virulent microorganisms appeared to reflect a paucity of proteins in the outer membrane (12). This concept could also explain the lack of humoral immune protection observed in T. denticola infections in our model. Moreover, host defense mechanisms are multifactorial, and the key antigenic components of T. denticola which elicit protective immunity and the effector mechanisms of the immunity remain undefined. In reviewing the outcomes of this investigation, we were forced to conclude that the humoral immune response to T. denticola, was not an effective host response. While differences in the humoral immune response in mice and humans are observed, this murine model suggested that protective immunity to T. denticola may be dependent on other immune mechanisms, such as cell-mediated immunity. Selected pathogens use a virulence strategy involving induction of antibody via activation of selected T-cell subsets and specific cytokine production. This antibody response not only may be ineffective in immune protection but also may protect the pathogens from an effective cell-mediated immune response. We propose that T. denticola may use this virulence strategy, and further studies to explore mechanisms for inducing and/or shifting the host response to increase T-cell or macrophage participation as an alternative to provide immune protection will be required.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by Public Health Service grant DE-11368 from the National Institute for Dental and Craniofacial Research.
We gratefully acknowledge the assistance of Stephen Walker, Michelle Steffen, and Pravina Patel.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Dept. of Periodontics, Univ. of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284. Phone: (210) 567-3600. Fax: (210) 567-6858. E-mail: ebersole{at}uthscsa.edu.
Editor: J. R. McGhee
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Alderete, J. F., and J. B. Baseman.
1979.
Surface-associated host proteins on virulent Treponema pallidum.
Infect. Immun.
26:1048-1056 |
| 2. | Allen, J. E., and R. M. Maizels. 1996. Immunology of human helminth infection. Int. Arch. Allergy Immun. 109:3-10[Medline]. |
| 3. | Armitage, G. C., W. R. Dickinson, R. S. Jenderseck, S. M. Levine, and D. W. Chambers. 1982. Relationship between the percentage of subgingival spirochetes and the severity of periodontal disease. J. Periodontol. 53:550-556[Medline]. |
| 4. | Aukhil, I., D. E. Lopatin, S. A. Syed, E. C. Morrison, and C. J. Kowalski. 1988. The effects of periodontal therapy on serum antibody (IgG) levels to plaque microorganisms. J. Clin. Periodontol. 15:544-550[Medline]. |
| 5. | Baughn, R. E., A. Jiang, R. Abraham, V. Ottmers, and D. M. Mucher. 1996. Molecular mimicry between an immunodominant amino acid motif on the 47-kDa lipoprotein of Treponema pallidum (Tpp47) and multiple repeats of analogous sequences in fibronectin. J. Immunol. 157:720-731[Abstract]. |
| 6. | Bellaby, T., K. Robinson, and D. Wakelin. 1996. Induction of differential T-helper-cell responses in mice infected with variants of the parasite nematode Trichuris muris. Infect. Immun. 64:791-795[Abstract]. |
| 7. |
Blakemore, R. P., and E. Canale-Parola.
1976.
Arginine catabolism by Treponema denticola.
J. Bacteriol.
128:616-622 |
| 8. | Briles, D. E., J. L. Claflin, K. Schroer, and C. Forman. 1981. Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature 294:88-90[Medline]. |
| 9. |
Carlsson, J.
1997.
Bacterial metabolism in dental biofilms.
Adv. Dent. Res.
11:75-80 |
| 10. |
Chen, P. B.,
M. E. Neiders,
S. J. Miller,
H. S. Reynolds, and J. J. Zambon.
1987.
Effect of immunization on experimental Bacteroides gingivalis infection in a murine model.
Infect. Immun.
55:2534-2537 |
| 11. |
Chen, P. B.,
L. B. Davern,
R. Schifferle, and J. J. Zambon.
1990.
Protective immunization against experimental Bacteroides (Porphyromonas) gingivalis infection.
Infect. Immun.
58:3394-3400 |
| 12. |
Cox, D. L.,
P. Chang,
A. W. McDowall, and J. D. Radolf.
1992.
The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum.
Infect. Immun.
60:1076-1083 |
| 13. |
Ebersole, J. L.
1990.
Systemic humoral immune responses in periodontal disease.
Crit. Rev. Oral Biol. Med.
1:283-331 |
| 14. |
Ebersole, J. L.,
D. Cappelli,
M.-N. Sandoval, and M. J. Steffen.
1995.
Antigen specificity of serum antibody in A. actinomycetumcomitans-infected periodontitis patients.
J. Dent. Res.
74:658-666 |
| 15. | Ebersole, J. L., D. E. Frey, M. A. Taubman, and D. J. Smith. 1980. An ELISA for measuring serum antibodies to Actinobacillus actinomycetumcomitans. J. Periodontal Res. 15:621-632[Medline]. |
| 16. | Ebersole, J. L., L. Kesavalu, S. L. Schneider, R. L. Machen, and S. C. Holt. 1995. Comparative virulence of periodontopathogens in a mouse abscess model. Oral Dis. 1:115-128[Medline]. |
| 17. |
Ellen, R. P.,
G. Lepine, and P.-M. Nghiem.
1997.
In vitro models that support adhesion specificity in biofilm of oral bacteria.
Adv. Dent. Res.
11:33-42 |
| 18. |
Holt, S. C., and T. E. Bramanti.
1991.
Factors in virulence expression and their role in periodontal disease pathogenesis.
Crit. Rev. Oral Biol. Med.
2:177-281 |
| 19. |
Huber, S. A., and B. Pfaeffle.
1994.
Differential Th1 and Th2 cell responses in male and female BALB/c mice with coxsackievirus group B type 3.
J. Virol.
68:5126-5132 |
| 20. | Jacob, E., T. F. Meiller, and R. K. Nauman. 1982. Detection of elevated serum antibodies to Treponema denticola in humans with advanced periodontitis by an enzyme-linked immunosorbent assay. J. Periodontal Res. 17:145-153[Medline]. |
| 21. | Johnson, B. D., and D. Engel. 1986. Acute necrotizing ulcerative gingivitis: a review of diagnosis, etiology and treatment. J. Periodontol. 57:141-150[Medline]. |
| 22. |
Kesavalu, L.,
J. L. Ebersole,
R. L. Machen, and S. C. Holt.
1992.
Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components.
Infect. Immun.
60:1455-1464 |
| 23. |
Kesavalu, L.,
S. C. Holt, and J. L. Ebersole.
1999.
Environmental modulation of oral treponeme virulence in a murine model.
Infect. Immun.
67:2783-2789 |
| 24. |
Kesavalu, L.,
S. C. Holt,
R. R. Crawley,
R. Borinski, and J. L. Ebersole.
1991.
Virulence of Wolinella recta in a murine abscess model.
Infect. Immun.
59:2806-2817 |
| 25. | Kesavalu, L., S. Walker, S. C. Holt, R. R. Crawley, and J. L. Ebersole. 1997. Virulence characteristics of oral treponemes in a murine model. Infect. Immun. 65:5096-5102[Abstract]. |
| 26. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[Medline]. |
| 27. | Lai, C.-H., M. A. Listgarten, C. I. Evian, and P. Dougherty. 1986. Serum IgA and IgG antibodies to Treponema vincentii and Treponema denticola in adult periodontitis, juvenile periodontitis and periodontally healthy subjects. J. Clin. Periodontol. 13:752-757[Medline]. |
| 28. | Lindblad, E. B., M. J. Elhay, R. Silva, R. Appelberg, and P. Anderson. 1997. Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect. Immun. 65:623-629[Abstract]. |
| 29. |
Loesche, W. J.
1988.
The role of spirochetes in periodontal disease.
Adv. Dent. Res.
2:275-283 |
| 30. |
Mangan, D. F.,
B. E. Laughon,
B. Bower, and D. E. Lopatin.
1982.
In vitro lymphocyte blastogenic responses and titers of humoral antibodies from periodontitis patients to oral spirochete isolates.
Infect. Immun.
37:445-451 |
| 31. | Martinez-Abrajan, D. M. 1993. Differential specific humoral response of susceptible and resistant mice infected with Mycobacterium lepraemurium. Rev. Latinoamericana Microbiol. 35:171-176. |
| 32. | Mountford, A. P., A. Fisher, and R. A. Wilson. 1994. The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni. Parasite Immunol. 16:521-527[Medline]. |
| 33. | Murray, P. A. 1994. HIV disease as a risk factor for periodontal disease. Compendium 15:1052-1063[Medline]. |
| 34. | Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241-251[Medline]. |
| 35. |
Radolf, J. D.,
T. E. Fehniger,
F. J. Silverblatt,
J. N. Miller, and M. A. Lovett.
1986.
The surface of virulent Treponema pallidum: resistance to antibody binding in the absence of complement and surface association of recombinant antigen 4D.
Infect. Immun.
52:579-585 |
| 36. | Rao, T. D., A. Fisher, and A. B. Frey. 1994. CD+ Th2 T cells elicited by immunization confers protective immunity to experimental Borrelia burgdorferi infection. Ann. N.Y. Med. Sci. 730:364-366. |
| 37. | Rice, M., and T. J. Fitzgerald. 1985. Immune immobilization of Treponema pallidum: antibody and complement interactions revisited. Can. J. Microbiol. 31:1147-1151[Medline]. |
| 38. |
Riviere, G. R.,
K. S. Weisz,
L. Simonson, and S. A. Lukehart.
1991.
Pathogen-related spirochetes identified within gingival tissue from patients with acute necrotizing ulcerative gingivitis.
Infect. Immun.
59:2653-2657 |
| 39. |
Riviere, G. R.,
K. S. Weisz,
D. F. Adams, and D. D. Thomas.
1991.
Pathogen-related oral spirochetes from dental plaque are invasive.
Infect. Immun.
59:3377-3380 |
| 40. | Rook, G. A., and J. L. Stanford. 1995. Adjuvants, endocrines and conserved epitopes; factors to consider when designing "therapeutic vaccines." Int. J. Immunopharmacol. 17:91-102[Medline]. |
| 41. | Rosenstein, D. I., G. R. Riviere, and K. Elott. 1993. HIV-associated periodontal disease: new oral spirochete found. J. Am. Dent. Assoc. 124:76-80[Abstract]. |
| 42. | Saunders, J. M., and J. D. Folds. 1985. Humoral response of the mouse to Treponema pallidum. Genitourin. Med. 61:221-229[Medline]. |
| 43. | Seiler, K. P., and J. J. Weis. 1996. Immunity to Lyme disease: protection, pathology and persistence. Curr. Opin. Immunol. 8:503-509[Medline]. |
| 44. |
Simonson, L. G.,
C. H. Goodman, and H. E. Morton.
1990.
Quantitative immunoassay of Treponema denticola serovar in adult periodontitis.
J. Clin. Microbiol.
28:1493-1496 |
| 45. |
Smibert, R. M., and J. A. Burmeister.
1983.
Treponema pectinovorum sp. nov. isolated from humans with periodontitis.
Int. J. Syst. Bacteriol.
33:852-856 |
| 46. | Smibert, R. M., J. L. Johnson, and R. R. Ranney. 1984. Treponema socranskii sp. nov., Treponema socranskii subsp. socranskii subsp. nov., Treponema socranskii subsp. buccale subsp. nov., and Treponema socranskii subsp. paredis subsp. nov. isolated from humans with experimental gingivitis and periodontitis. Int. J. Syst. Bacteriol. 34:456-462. |
| 47. |
Snapper, C. M., and W. E. Paul.
1987.
Inteferon- and B cell stimulatory factor-1 reciprocally regulate IgG isotype production.
Science
236:944-947 |
| 48. |
Tew, J. G.,
D. R. Marshall,
W. E. C. Moore,
A. M. Best,
K. G. Palcanis, and R. R. Ranney.
1985.
Serum antibody reactive with predominant organisms in the subgingival flora of young adults with generalized severe periodontitis.
Infect. Immun.
48:303-311 |
| 49. | Tew, J. G., R. M. Smibert, E. A. Scott, J. A. Burmeister, and R. R. Ranney. 1985. Serum antibodies in young adult humans reactive with periodontitis associated treponemes. J. Periodontal Res. 20:580-586[Medline]. |
| 50. |
Umemoto, T.,
F. Nakazawa,
E. Hoshino,
K. Okada,
M. Fukunaga, and I. Namikawa.
1997.
Treponema medium sp. nov., isolated from human subgingival dental plaque.
Int. J. Syst. Bacteriol.
47:67-72 |
| 51. |
Walker, S. G.,
J. L. Ebersole, and S. C. Holt.
1997.
Identification, isolation, and characterization of the 42-kilodalton major outer membrane protein (MompA) from Treponema pectinovorum ATCC 33768.
J. Bacteriol.
179:6441-6447 |
| 52. | Westbay, T. D., C. C. Dascher, R. Hsia, M. Zauderer, and P. M. Bavoil. 1995. Deviation of immune response to Chlamydia psittaci outer membrane protein in lipopolysaccharide-hyporesponsive mice. Infect. Immun. 63:1391-1393[Abstract]. |
| 53. | Wicher, K., S. M. Wos, and V. Wicher. 1986. Kinetics of antibody response of pathogenic and nonpathogenic treponemes in experimental syphilis. Sex. Transm. Dis. 13:251-257[Medline]. |
| 54. |
Wyss, C.,
B. K. Choi,
P. Schupbach,
B. Guggenheim, and U. B. Gobel.
1996.
Treponema maltophilum sp. nov., a small oral spirochete isolated from human periodontal lesions.
Int. J. Syst. Bacteriol.
46:745-752 |
| 55. |
Wyss, C.,
B. K. Choi,
P. Schupbach,
B. Guggenheim, and U. B. Gobel.
1997.
Treponema amylovorum sp. nov., a saccharolytic spirochete of medium size isolated from an advanced human periodontal lesion.
Int. J. Syst. Bacteriol.
47:842-845 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»